A recent Business Wire article discussed a new partnership that aims to alleviate pressure created by drug shortages. Civica Rx announced last week that it has signed a long-term deal with Thermo Fisher Scientific to develop and manufacture essential medications that have a history of shortages. Civica is a not-for profit drug and pharmaceutical company that was started by national philanthropies in 2018 to combat shortages and high prices of urgently needed generic drugs.
